Clinical trial
Vascular Reactivity Assessment by AngioDefender -- A Repeatability and Reproducibility Study
NCT02641197 is registered in ClinicalTrials.gov with Everist Genomics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vascular Reactivity Assessment by AngioDefender -- A Repeatability and Reproducibility Study
- Lead sponsor
- Everist Genomics, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 6, 2016
- Completion date
- May 19, 2016
- Enrollment
- 20 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.